DEKA SmartXide DOT Fractional CO2 Laser
DEKA
Medical laser deviceFractional ablative CO2 laser for aesthetic dermatology and dermatologic surgery
Certifications
- CE Marked medical device under EU Medical Device Directive 93/42/EEC (legacy MDD classification, model Specific)
- Manufactured under ISO 9001 quality management system
- Manufactured under ISO 13485 quality management system for medical devices
- Designed and tested in accordance with applicable IEC 60601 series standards for medical electrical equipment (platform Level)
- Laser safety classification and labelling compliant with IEC 60825 1 for laser products
- CE Marked medical device under EU Medical Device Directive 93/42/EEC (legacy MDD classification, model Specific)
- Manufactured under ISO 9001 quality management system
- Manufactured under ISO 13485 quality management system for medical devices
- Designed and tested in accordance with applicable IEC 60601 series standards for medical electrical equipment (platform Level)
- Laser safety classification and labelling compliant with IEC 60825 1 for laser products
Fractional ablative CO2 laser for aesthetic dermatology and dermatologic surgery
Description
The DEKA SmartXide DOT is a floor-standing fractional CO2 laser system designed for skin resurfacing, rejuvenation and dermatologic surgery. It delivers a 10.6 µm CO2 beam via an articulated arm and DOT scanning handpiece, creating microscopic columns of ablation (DOT Therapy) while leaving surrounding tissue intact to speed healing. SmartPulse and SmartStack technologies allow precise control of pulse shape, depth of vaporisation and thermal effect, enabling treatments from light fractional rejuvenation to more aggressive resurfacing for wrinkles, scars and photoaged skin. A 4-year-old pre-owned unit retains these core features, but condition, software level and accessories should be verified against the original specification and service history.
Bnefits
- Fractional ablative CO2 technology for effective skin resurfacing with controlled downtime
- SmartPulse emission for well-controlled energy delivery to minimise collateral thermal damage
- SmartStack function to precisely control vaporisation depth and cumulative thermal effect at each DOT
- Treats fine and deep wrinkles, acne and surgical scars, and photoaging-related texture and pigment changes
- Improves skin laxity and stimulates neocollagenesis for long-term tightening and texture improvement
- Adjustable density, power, dwell time and scan patterns to tailor treatments to each patient and indication
- Articulated arm and scanner handpiece for ergonomics and reproducible coverage
- Compatible with a wide range of dermatologic and minor surgical procedures
- Well-established clinical track record with CO2 fractional resurfacing
- CE-marked medical device manufactured under ISO 9001 and ISO 13485 quality systems
Indications
- Fractional ablative skin resurfacing of the face and body
- Photoaging (sun damage) including rough texture, dyschromia and enlarged pores
- Fine and deep wrinkles and rhytides
- Acne scars and other atrophic scars
- Surgical and traumatic scars
- Skin laxity and mild to moderate skin tightening
- Benign pigmented lesions as indicated in local labelling
- Cutaneous surgery and minor dermatologic procedures within the approved indications for the CO2 laser platform
Composition
- Energy source: CO2 laser, wavelength 10.6 µm (fractional and traditional emission)
- Maximum output power to tissue approximately 30 W (model-dependent)
- Fractional DOT scanning system with adjustable scan size (up to about 15 mm × 15 mm) and dot spacing
- Articulated 7-mirror delivery arm with scanner and surgical handpieces (configuration-dependent)
- Integrated touchscreen console with SmartPulse and SmartStack pulse-shaping control
- Aiming beam: visible red diode (approximately 635–670 nm)
- System weight approximately 38–95 kg depending on configuration and trolley
- Electrical requirements typically 100–120 V / 220–230 V AC, 50/60 Hz (country-specific)
Formulation
- Energy-based device: fractional ablative CO2 laser platform
- Emission modes: fractional DOT scanning, traditional resurfacing and surgical CO2 emission (configuration-dependent)
- SmartPulse technology for shaped pulses (vaporisation with controlled thermal component)
- SmartStack technology allowing multiple sequential pulses in the same DOT to increase tightening while controlling depth
- Range of scan patterns and densities for customised coverage
- Multiple handpieces and scanners available for dermatology, aesthetic and minor surgical indications
Packaging
- Floor-standing console on wheeled trolley with integrated touchscreen user interface
- Articulated arm with fractional scanner handpiece (HiScan DOT or equivalent, depending on configuration)
- Keyed main power switch and emergency stop button on front panel
- Footswitch for laser activation
- Manufacturer-supplied operator manual and safety documentation
- Protective eyewear for patient and operator (laser-specific, supplied per local distributor and configuration)
- Additional surgical or specialised handpieces and smoke-evacuation connection where included in the original package
Usage
- Use only by trained and appropriately licensed medical professionals familiar with CO2 laser safety and local regulations.
- Before treatment, perform a full medical history, skin assessment and indication/contraindication check; obtain informed consent.
- Configure treatment parameters (power, dwell time, SmartStack level, dot density, scan size and pattern) according to indication, skin type and desired downtime, following the official user manual and clinical guidelines.
- Provide appropriate eye protection for patient, operator and any assistants; ensure laser warning signage and controlled access to the treatment room.
- Cleanse the treatment area, remove all makeup and topical products, and consider topical or local anaesthesia as per clinic protocol.
- Position the articulated arm and scanner perpendicular to the skin at the recommended working distance; perform test spots when changing parameters or treating new areas.
- Scan the treatment area systematically, avoiding excessive overlap beyond what is recommended for the selected density and SmartStack settings.
- After treatment, apply appropriate post-procedure care (cooling, barrier ointments, photoprotection) and provide written aftercare instructions including sun avoidance and wound-care guidance.
- Schedule follow-up to monitor healing, manage any adverse effects and plan further sessions if required.
- For a 4-year-old pre-owned unit, verify that all safety checks, preventative maintenance and calibrations are up to date and that operation remains within manufacturer specifications before clinical use.
Contraindications
- Known photosensitivity or hypersensitivity to light or laser exposure within the treatment parameters
- Active infection, open wounds, or inflammatory skin disease (e.g. herpes simplex flare, bacterial or fungal infection) in the treatment area
- History of abnormal wound healing, keloid or hypertrophic scarring without careful risk–benefit assessment
- Recent isotretinoin therapy or other medications known to impair wound healing, within the timeframe specified in current clinical guidelines
- Uncontrolled systemic disease (e.g. poorly controlled diabetes, bleeding disorders) that may impair healing or increase procedural risk
- Pregnancy or breastfeeding where local policy or labelling advises against elective laser resurfacing procedures
- Recent intense sun exposure or tanning that significantly increases risk of post-inflammatory hyperpigmentation
- Any other contraindications listed in the official DEKA SmartXide DOT (or associated platform) operator’s manual or local regulatory labelling
Adverse Effects
- Expected transient erythema, oedema and a sunburn-like sensation in the treated area
- Crusting, oozing and exfoliation during the early healing phase following ablative fractional resurfacing
- Temporary changes in skin pigmentation including post-inflammatory hyperpigmentation or hypopigmentation, particularly in darker phototypes or after sun exposure
- Risk of infection including bacterial, viral (e.g. herpes simplex reactivation) or fungal infection in inadequately protected or cared-for skin
- Prolonged erythema, delayed healing or milia formation in healing skin
- Rare risk of scarring, textural irregularities or persistent dyschromia, especially with aggressive settings or improper aftercare
- Discomfort or pain during and immediately after treatment if anaesthesia and cooling are insufficient
- Eye injury if appropriate protective measures are not strictly followed
Storage Conditions
- Install and store the system in a clean, dry, temperature-controlled clinical environment within the operating range specified in the operator’s manual (typically standard indoor room temperature and non-condensing humidity).
- Keep the device on a stable, level surface; lock the wheels when the system is in place.
- Protect the articulated arm, handpieces and scanner optics from dust, impact and contamination; use protective covers when not in use.
- Disconnect from mains power during long periods of non-use and during service operations as recommended by the manufacturer.
- Follow all additional storage, transport and environmental conditions specified in the official DEKA documentation.
Duration
Typical fractional facial treatment sessions last approximately 15\u201345 minutes depending on area size, density, SmartStack level and whether multiple passes or additional surgical steps are performed.
Onset
Re-epithelialisation generally occurs over 5\u201310 days with visible initial improvement in texture and pigmentation once crusting and erythema subside; neocollagenesis and tightening effects continue to develop over approximately 3\u20136 months after a treatment course.
